0001485003-17-000028.txt : 20170405
0001485003-17-000028.hdr.sgml : 20170405
20170405161512
ACCESSION NUMBER: 0001485003-17-000028
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170403
FILED AS OF DATE: 20170405
DATE AS OF CHANGE: 20170405
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001485003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262025616
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-444-8550
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HURLY STEPHEN A
CENTRAL INDEX KEY: 0001130637
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36296
FILM NUMBER: 17742742
MAIL ADDRESS:
STREET 1: C/O ELEVEN BIOTHERAPEUTICS
STREET 2: 215 FIRST ST. #400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
wf-form4_149142329801580.xml
FORM 4
X0306
4
2017-04-03
0
0001485003
Eleven Biotherapeutics, Inc.
EBIO
0001130637
HURLY STEPHEN A
C/O ELEVEN BIOTHERAPEUTICS, INC.
245 FIRST STREET, SUITE 1800
CAMBRIDGE
MA
02142
1
1
0
0
President and CEO
Employee Stock Option (Right to Buy)
2.28
2017-04-03
4
A
0
32692
0
A
2027-04-02
Common Stock
32692.0
32692
D
50% of the shares subject to such option shall vest on grant date, with the remaining 50% of shares underlying the option to vest on the first anniversary of the grant date.
/s/ Stephen A. Hurly
2017-04-05